期刊文献+
共找到11篇文章
< 1 >
每页显示 20 50 100
Ⅱ型糖尿病血浆PAI-1、t-PA检测的意义和结果评价 被引量:6
1
作者 丁磊 夏文权 +1 位作者 余文红 胡翊群 《血栓与止血学》 2002年第1期20-22,25,共4页
目的:通过对Ⅱ型糖尿病患者分组(伴血管病变组、胰岛素抵抗组、胰岛素抵抗伴血管病变组、Ⅱ型糖尿病组)检测PAI-1、t-PA抗原及活性,并计算抗原比和活性比,以评价各检测指标的临床价值。方法:采用ELISA法检测PAI-1及t-PA抗原,采用发色底... 目的:通过对Ⅱ型糖尿病患者分组(伴血管病变组、胰岛素抵抗组、胰岛素抵抗伴血管病变组、Ⅱ型糖尿病组)检测PAI-1、t-PA抗原及活性,并计算抗原比和活性比,以评价各检测指标的临床价值。方法:采用ELISA法检测PAI-1及t-PA抗原,采用发色底物法检测PAl-1、t-PA活性。结果:189例标本总体患病组及分组后各组的PAI-1活性、t-PA活性及t-PA活性/PAI-1活性比值与正常对照组比较均有显著性差异(P<0.05)。患病组间除t-PA抗原,其余检测显示胰岛素抵抗组、胰岛素抵抗组伴血管病变组与Ⅱ型糖尿病组存在显著性差异(P<0.05)。结论:在上述检测指标中t-PA活性、PAI-1活性反映血管病变的发生较敏感,t PA/PAI-1的活性比值更具临床应用价值。 展开更多
关键词 胰岛素抵抗 组织纤溶酶激活 Ⅰ型组织纤溶酶 原激活抑制物 临床意义 血管病变 Ⅱ型糖尿病
下载PDF
洛伐他汀对不稳定型心绞痛患者血浆内皮依赖性血管舒缩因子水平的影响
2
作者 曹庆博 王东 +3 位作者 刘云启 胡燕华 张玉传 马建群 《滨州医学院学报》 2003年第3期164-165,共2页
目的 :探讨洛伐他汀对不稳定型心绞痛患者血浆内皮依赖性血管舒缩因子内皮素 ( ET- 1 )、一氧化氮 ( NO)、6-酮前列腺素 F1α( 6- keto- PGF1α)及血浆纤溶酶原激活抑制物 - 1 ( PAI- 1 )的影响。方法 :将 70例不稳定型心绞痛患者随机... 目的 :探讨洛伐他汀对不稳定型心绞痛患者血浆内皮依赖性血管舒缩因子内皮素 ( ET- 1 )、一氧化氮 ( NO)、6-酮前列腺素 F1α( 6- keto- PGF1α)及血浆纤溶酶原激活抑制物 - 1 ( PAI- 1 )的影响。方法 :将 70例不稳定型心绞痛患者随机分成洛伐他汀治疗组 35例及常规治疗组 35例 ,比较观察治疗前和治疗 2个月后血浆 ET- 1、NO、6- keto- PGF1α、PAI- 1水平的变化。结果 :1洛伐他汀治疗 2个月后 TC、TG、LDL- C降低 ,HDL-C升高 ,有显著性差异 ;2洛伐他汀治疗 2个月后 ,ET- 1、PAI- 1降低 ,NO、6- keto- PGF1α升高 ,有显著性差异 ;与常规治疗组相比 ,ET- 1、PAI- 1降低 ,NO、6- keto- PGF1α升高 ,有显著性差异。结论 展开更多
关键词 不稳定型心绞痛(UAP) 内皮素-1(ET-1) 一氧化氮(NO) 6-酮前列腺素F1α(6-ketoPGF1α) 纤溶醉原激活抑制物-1(PAI-1)
下载PDF
An Experimental Study of Pathogenesis of Steroid-induced Avascular Necrosis of Femoral Head 被引量:1
3
作者 李毅 陈君长 +3 位作者 康斌 王坤正 张珍妮 同志超 《Journal of Nanjing Medical University》 2003年第4期191-195,共5页
Objective: To explore the pathogenesis of avascular necrosis of femoral head(ANFH) and search an effective method for clinical practice. Methods: Twenty-four Japanese rabbitswere divided into 2 groups of models and co... Objective: To explore the pathogenesis of avascular necrosis of femoral head(ANFH) and search an effective method for clinical practice. Methods: Twenty-four Japanese rabbitswere divided into 2 groups of models and controls. ANFH models were produced byintramuscular-injection of large dosage of steroid to rabbits for 8 weeks. From the 4th, 8th and12th week after production of models, 2 rabbits of each group were sacrificed to observe thestructure of femoral head through light microscope and scanning electron microscope. The contents ofNitric Oxide (NO), tissue-type plasminogen activator (t-PA) and -plasminogen activator inhibitor(PAI) in plasma of the 4 rabbits in each group were estimated at the same time. Results: Comparedwith control group, the rabbits of model group exhibited many differences: such as osteoporosis offemoral head, the presence of more bone lacuna and fat cell through light microscope observing; thebroken and sunk bone trabecula, the loosen and broken collagen fibers on the surface of bone matrixthrough scanning electron microscope observing. Compared with control group, the Concentration ofNO and t-PA in plasma of the model rabbits decreased obviously, but the Concentration of the PAIincreased obviously. Conclusion: The steroid-induced ANFH might be related to the lower level of NOand the descent of fibrinolytic activity. 展开更多
关键词 femoral head necrosis pathological process nitric oxide tissue-typeplasminogen activator plasminogen activator inhibitor
下载PDF
白塞氏病患者血清t-PA、PAI的变化及临床意义
4
作者 王红 李启宁 +2 位作者 丁从珠 孙凌云 张杏书 《江苏医药》 CAS CSCD 北大核心 2001年第6期404-405,共2页
目的 检测白塞氏病 (BD)患者血清组织纤溶酶原激活剂 (t PA)、组织纤溶酶原激活剂抑制物 (PAI)水平的变化 ,并探讨与疾病的相关性。方法 应用发色底物法测定 2 4例BD患者血清t PA、PAI水平 ,并分疾病活动组、稳定组与正常对照组相比... 目的 检测白塞氏病 (BD)患者血清组织纤溶酶原激活剂 (t PA)、组织纤溶酶原激活剂抑制物 (PAI)水平的变化 ,并探讨与疾病的相关性。方法 应用发色底物法测定 2 4例BD患者血清t PA、PAI水平 ,并分疾病活动组、稳定组与正常对照组相比较。结果 BD组t PA水平较正常对照组显著降低 (P <0 0 5 ) ,而PAI水平则显著升高 (P <0 0 5 ) ,BD活动组t PA水平较稳定组非常显著降低 (P <0 0 1) ,PAI水平则非常显著升高 (P <0 0 1)。结论 纤溶凝血系统可能在BD发病机制中起一定作用 ,并与疾病活动有密切相关性。 展开更多
关键词 白塞氏病 组织纤溶酶激活 组织纤溶激活抑制
下载PDF
PAI-1对人骨髓间充质干细胞骨向分化的影响 被引量:1
5
作者 金赫秀 王飘 +1 位作者 王学玖 陈仁吉 《北京口腔医学》 CAS 2020年第1期12-15,共4页
目的利用裸鼠动物模型,观察骨向分化过程中纤溶蛋白酶原激活剂抑制物-1(PAI-1)诱导人骨髓间充质干细胞(hBMSCs)骨向分化的能力。方法取拔牙时磨除的骨组织分离及培养hBMSCs,应用茜素红S染色检测向成骨细胞分化程度,并应用real-time PCR... 目的利用裸鼠动物模型,观察骨向分化过程中纤溶蛋白酶原激活剂抑制物-1(PAI-1)诱导人骨髓间充质干细胞(hBMSCs)骨向分化的能力。方法取拔牙时磨除的骨组织分离及培养hBMSCs,应用茜素红S染色检测向成骨细胞分化程度,并应用real-time PCR检测骨向分化的标志性基因(ALP、BSP、Col1、OCN、Run×2)的表达。然后,将hBMSCs移植到BALB/c裸鼠体内,采用组织学检查检测PAI-1在体内诱导hBMSCs形成骨组织能力。结果PAI-1不仅诱导hBMSCs向成骨细胞分化,还诱导ALP、BSP、Col1、OCN、Run×2基因的高表达。在体内PAI-1可诱导hBMSCs分化成骨组织,而且PAI-1诱导Col1和BSP在新生骨组织中的高表达。结论PAI-1可促进hBMSCs向成骨细胞分化及在体内诱导hBMSCs分化成骨组织。 展开更多
关键词 纤溶蛋白酶激活抑制-1 人骨髓间充质干细胞 骨向分化
下载PDF
INVESTIGATION OF THROMBOMODULIN AND PLASMINOGEN ACTIVATOR INHIBITOR TYPE-I IN PREGNANCY INDUCED HYPERTENSION AND ITS CLINICAL SIGNIFICANCE 被引量:6
6
作者 马水清 白春梅 边旭明 《Chinese Medical Sciences Journal》 CAS CSCD 2001年第3期169-171,共3页
Objective. To measure the circulating levels of thrombomodulin (TM) and plasminogen activator inhibitor type- I (PAI- I) in women with pregnancy induced hypertension (PIH). Methods. Blood samples were drawn from 97 pr... Objective. To measure the circulating levels of thrombomodulin (TM) and plasminogen activator inhibitor type- I (PAI- I) in women with pregnancy induced hypertension (PIH). Methods. Blood samples were drawn from 97 pregnant women in their third trimester, grouped as 25 mild PIH,26 moderate PIH,22 severe PIH and 24 normotensive healthy pregnant women for determining levels of TM by ELISA,PAI- I by colorimetric assay methods, and creatinine (Cr) in serum by biochemical method. Results. Circulating levels of TM, PAI- I and TM/Cr ratio increased with increasing severity of PIH. There were no significant differences between mild and normotensive pregnant women. The parameters were significantly changed in the moderate and severe PIH groups. Conclusion. TM and PAI- I may serve as meaningful clinical markers for the assessment of the endothelial damage in PIH, which is very important in evaluating and following the development of PIH. 展开更多
关键词 pregnancy complication HYPERTENSION plasminogen activator inhibitor THROMBOMODULIN
下载PDF
High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis 被引量:5
7
作者 Parichut Thummarati Sitsom Wijitburaphat +4 位作者 Aruna Prasopthum Apaporn Menakongka Banchob Sripa Rutaiwan Tohtong Tuangporn Suthiphongchai 《World Journal of Gastroenterology》 SCIE CAS CSCD 2012年第3期244-250,共7页
AIM: To investigate the role of urokinase plasminogen activator (uPA) in cholangiocarcinoma (CCA) invasion and its correlation with clinicopathological parameters. METHODS: uPA expression in CCA tissue was determined ... AIM: To investigate the role of urokinase plasminogen activator (uPA) in cholangiocarcinoma (CCA) invasion and its correlation with clinicopathological parameters. METHODS: uPA expression in CCA tissue was determined by immunohistochemistry. The level of uPA from two CCA cell lines (HuCCA-1 and KKU-M213) and a noncancer immortalized cholangiocyte cell line (H69) was monitored by plasminogen-gelatin zymography and western blotting, whereas that of plasminogen activator inhibitor type 1 (PAI-1) protein and uPA receptor (uPAR)mRNA was monitored by western blotting and quantitative real-time reverse transcriptase polymerase chain reaction, respectively. Two independent methods were employed to suppress uPA function: a synthetic uPA inhibitor (B428) and silencing of uPA gene expression using siRNA. In vitro invasion of the uPA-disrupted cells was assessed by Matrigel-coated Transwell assay. RESULTS: The immunohistochemical study showed that 75.3% (131/174) of CCA tissues expressed uPA. High uPA expression was correlated with lymphatic invasion and metastasis of CCA patients. Plasminogen-gelatin zymography of the conditioned media and cell-surface eluates showed that both CCA cell lines, but not H69, expressed both secreted and membrane-bound forms of uPA. Although the two CCA cell lines, HuCCA-1 and KKU-M213, expressed a relatively high level of uPA and uPAR, the latter exhibited a much lower degree of in vitro invasiveness, correlating with a high expression of PAI-1 in the latter, but not in the former. Suppressing uPA function with a specific uPA inhibitor, B428, or with siRNA against uPA reduced in vitro invasiveness of KKU-M213 cells, demonstrating the requirement for uPA in the invasiveness of CCA cells. Therefore, our in vivo and in vitro studies suggest that uPA is an important requirement for the invasion process of CCA. CONCLUSION: uPA expression correlates with lymphatic invasion and metastasis in vivo and is required for CCA cell invasion in vitro , suggesting its potential as a therapeutic target. 展开更多
关键词 Bile duct cancer Cholangiocarcinoma Cancer invasion Urokinase plasminogen activator Cancer metastasis
下载PDF
Expression of Plasminogen Activator Inhibitor-2 is Negatively Associated with Invasive Potential in Hepatocellular Carcinoma Cells
8
作者 Ye Jin Li Zhou +1 位作者 Ke-min Jin Bao-cai Xing 《Chinese Medical Sciences Journal》 CAS CSCD 2013年第1期16-19,共4页
Objective To investigate the association between plasminogen activator inhibitor(PAI)-2 expression and invasive potential in hepatocellular carcinoma(HCC) cells.Methods The HCC cell lines with high,low,and non-metasta... Objective To investigate the association between plasminogen activator inhibitor(PAI)-2 expression and invasive potential in hepatocellular carcinoma(HCC) cells.Methods The HCC cell lines with high,low,and non-metastatic potentials,namely MHCC97-H,MHCC97-L,and SMMC-7721 respectively,were cultured in vitro.Matrigel invasion assay and Western blot of PAI-2 protein expression were conducted.Results The number of invaded cells in MHCC97-L was significantly higher than that in SMMC-7721(P=0.005),whereas that in MHCC97-H was higher than in MHCC97-L(P=0.017) and SMMC-7721(P=0.001).Contrarily,PAI-2 protein expression was gradually reducing from SMMC-7721,MHCC97-L,to MHCC97-H(MHCC97-H vs.MHCC97-L,P<0.001;MHCC97-H vs.SMMC-7721,P=0.001;MHCC97-L vs.SMMC-7721,P=0.001).The Pearson's correlation analysis revealed a significant negative association between invaded cell number and PAI-2 expression(r= 0.892,P=0.001).Conclusion PAI-2 expression may be negatively associated with the invasive potential of HCC. 展开更多
关键词 hepatocellular carcinoma plasminogen activator inhibitor-2 invasive potential
下载PDF
Tissue-type plasminogen activator and plasminogen activator inhibitor type-1 mRNA and their protein expression levels in human decidua after early pregnancy termination by mifepristone plus misoprostol
9
作者 黄丽丽 石一复 《Chinese Medical Journal》 SCIE CAS CSCD 2001年第6期68-71,108,共5页
Objective To investigate the mechanism of prolonged uterine hemorrhage after terminating early pregnancy by mifepristone plus misoprostol.Methods Forty-five decidua specimens were obtained from 45 pregnant women wit... Objective To investigate the mechanism of prolonged uterine hemorrhage after terminating early pregnancy by mifepristone plus misoprostol.Methods Forty-five decidua specimens were obtained from 45 pregnant women with amenorrhea of 6-7 week duration. Fifteen women were treated with mifepristone and 15 were treated with mifepristone plus misoprostol. The remaining 15 served as controls. The tPA and PAI-1 mRNA levels were estimated by reverse transcription-polymerase chain reaction. Chromogenic assay and enzyme-linked immunosorbent assay were used to detect tPA activity and PAI-1 protein level in decidua. Results The activities of tPA in the mifepristone plus misoprostol group and in the mifepristone group were 46.91±20.74?IU/mg*protein and 64.25±35.81?IU/mg*protein respectively, lower than those in the normal decidua group (99.76±58.61?IU/mg*protein, P<0.05). tPA mRNA levels in the mifepristone plus misoprostol group were the highest (1.43±0.39) among the groups. In the mifepristone group, tPA mRNA level (0.90±0.16) was not significantly different from that in the normal decidua group (0.94±0.17). The protein and mRNA expression levels of PAI-1 were not significantly different among the three groups (P>0.05).Conclusions Mifepristone plus misoprostol decreased tPA activity in human early decidua by post-transcription pathways, which may influence decidua shedding, endometrial angiogenesis, endometrial remodeling, and cause prolonged uterine hemorrhage after drug abortion. 展开更多
关键词 tissue-type plasminogen activator · plasminogen activator inhibitor type-1 · mifepristone · decidua · uterine hemorrhage
原文传递
Endothelium-specific SIRT1 overexpression inhibits hyperglycemia-induced upregulation of vascular cell senescence 被引量:16
10
作者 CHEN HouZao WAN YanZhen +9 位作者 ZHOU Shuang LU YunBiao ZHANG ZhuQin ZHANG Ran CHEN Feng HAO DeLong ZHAO Xiang GUO ZhiChen LIU DePei LIANG ChihChuan 《Science China(Life Sciences)》 SCIE CAS 2012年第6期467-473,共7页
The rapidly increasing prevalence of diabetes mellitus worldwide is one of the most serious and challenging health problems in the 21st century. Mammalian sirtuin 1 (SIRT1) has been shown to decrease high-glucose-in... The rapidly increasing prevalence of diabetes mellitus worldwide is one of the most serious and challenging health problems in the 21st century. Mammalian sirtuin 1 (SIRT1) has been shown to decrease high-glucose-induced endothelial cell senescence in vitro and prevent hyperglycemia-induced vascular dysfunction. However, a role for SIRTI in prevention of hyperglyce- mia-induced vascular cell senescence in vivo remains unclear. We used endothelium-specific SIRT1 transgenic (SIRT1-Tg) mice and wild-type (WT) mice to construct a 40-week streptozotocin (STZ)-induced diabetic mouse model. In this mode, 42.9% of wild-type (WT) mice and 38.5% of SIRT1-Tg mice were successfully established as diabetic. Forty weeks of hyper- glycemia induced significant vascular cell senescence in aortas of mice, as indicated by upregulation of expression of senes- cence-associated markers including p53, p21 and plasminogen activator inhibitor-1 (PAI-1). However, SIRT1-Tg diabetic mice displayed dramatically decreased expression of p53, p21 and PAI-I compared with diabetic WT mice. Moreover, man- ganese superoxide dismutase expression (MnSOD) was significantly downregulated in the aortas of diabetic WT mice, but was preserved in diabetic SIRT1-Tg mice. Furthermore, expression of the oxidative stress adaptor p66Shc was significantly de- creased in aortas of SIRT1-Tg diabetic mice compared with WT diabetic mice. Overall, these findings suggest that SIRT 1-mediated inhibition of hyperglycemia-induced vascular cell senescence is mediated at least partly through the reduction of oxidative stress. 展开更多
关键词 SIRT1 HYPERGLYCEMIA vascular cell senescence
原文传递
Assessment of ghrelin and leptin receptor levels in postmenopausal women who received oral or transdermal menopausal hormonal therapy
11
作者 Barbara RUSZKOWSKA Alina SOKUP +4 位作者 Arleta KULWAS Maciej W.SOCHA Krzysztof GóRALCZYK Barbara GóRALCZYK Danuta ROS 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2012年第1期35-42,共8页
Objective: In postmenopausal women, an increased leptin concentration and reduced levels of ghrelin and adiponectin were observed. The aim of this study was to evaluate the concentrations of the active form of ghreli... Objective: In postmenopausal women, an increased leptin concentration and reduced levels of ghrelin and adiponectin were observed. The aim of this study was to evaluate the concentrations of the active form of ghrelin, total ghrelin, leptin receptor, lipoprotein(a) (Lp(a)), and plasminogen activator inhibitor type 1 (PAl-l) in postmenopausal women who received oral or transdermal menopausal hormonal therapy (MHT). Methods: The study involved 76 healthy women: 46 women aged from 44 to 58 years who received oral (26) or transdermal (20) MHT; the control group consisted of 30 women aged from 44 to 54 years who did not receive MHT. The plasma concentrations of total ghrelin, the active form of ghrelin, Lp(a), and PAI-I:Ag were measured by enzyme-linked immunosorbent assay (ELISA). The concentration of the leptin receptor was measured by enzyme immunometric assay (EIA). Results: We observed a significantly higher concentration o~ total ghrelin and the active form of ghrelin in women who received transdermal MHT in comparison with those who took oral MHT. We also found a significantly lower concentration of total ghrelin in women who received oral MHT compared with the control group. A higher concentration of PAl-1 :Ag was found in the group of women who took transdermal MHT in comparison with those who took oral MHT and with the control group. The differences were statistically significant. Additionally, we found a significant negative correlation between the concentrations of total ghrelin and PAl-1 :Ag and a positive correlation between the concentrations of total ghrelin and leptin receptor in women who received transdermal MHT. Conclusions: The study showed that women who used transdermal MHT had higher levels of total ghrelin than women who took oral MHT. This indicates a beneficial effect of the transdermal route of MHT. However, transdermal therapy was associated with adverse effects with regard to the observed higher levels of PAl-1 :Ag, which in turn, can lead to a reduction in fibrinolytic activity. 展开更多
关键词 Menopausal hormonal therapy (MHT) Plasminogen activator inhibitor type 1 (PAl-l) Leptin receptor GHRELIN MENOPAUSE
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部